Groundbreaking stem cell therapy trial for Alzheimer’s disease underway at UTHealth Houston

A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer’s disease is underway at UTHealth Houston.

Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn – Pharmaceutical Technology

Share this article Deciphera also brings ripretinib, marketed under the brand name Qinlock, to the deal. Credits: ESB Professional/Shutterstock.com Deciphera Pharmaceuticals is set to be

April 29, 2024

Immunology biotech Inmagene to join Nasdaq through reverse merger with what’s left of Ikena

Inmagene Biopharmaceuticals, a biotech developing immunology treatments, will take over the Nasdaq listing of Ikena Oncology in a reverse merger that ends the target company’

December 25, 2024

Study shows how chronic sleep loss can damage the heart

Does this sound like you? You wake up at the same time each morning, get the kids out the door, and rush to catch the

October 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.